9results about How to "The result is valid" patented technology

Treatment of hyperinsulinemic hypoglycemia comprises administration of an effective amount of a glucagon-like peptide-1 receptor antagonist (GLP1RA) alone or in combination with an amylinomimetic agent or any anti-gastric emptying agent. Patients suffering from hyperinsulinemic hypoglycemia after bariatric surgery experience particular benefit, as there is no current method effective for their treatment. Prevention or reduction of acute adverse effects of postprandial hypoglycemia, such as palpitations, tremor, weakness, sweating, confusion, fatigue, blurred vision, seizures, or loss of consciousness, and prevention of chronic adverse effects of hyperinsulinemic hypoglycemia, such as cognitive impairment, can be achieved by treatment with GLP1RA.

This application provides a method and system for correcting the brightness temperature of a spaceborne one-dimensional integrated aperture microwave radiometer. The method includes: acquiring two-dimensional observed brightness temperature data O along the vertical satellite orbit and along the satellite orbit for different ascent and descent orbits of the microwave radiometer; acquiring external data such as atmospheric profiles, surface data, and sea surface salinity along the radiation transmission path to obtain simulated Earth radiation brightness temperature data B, and removing outlier data; subtracting the observed brightness temperature data from the simulated brightness temperature data to obtain O-B data for multiple single orbits, and removing outlier data; taking the median of the O-B data to obtain the average difference in O-B brightness temperature and the two-dimensional corrected brightness temperature; dividing the average difference in O-B brightness temperature by the observed brightness temperatures in the corresponding two vertical directions to obtain two-dimensional relative brightness temperature correction coefficients based on different ascent and descent orbits; and correcting the observed brightness temperature using the two-dimensional relative brightness temperature correction coefficients or the two-dimensional corrected brightness temperature. The advantage of this application is that the established two-dimensional correction coefficients have a better correction effect.

The invention discloses a gene sequence alignment and variation detection system and method based on cloud computing, and belongs to the technical field of gene detection.The gene sequence alignment and variation detection system comprises a gene collection terminal used for managing users and collecting real-time data of gene sequences of the users; the data communication module is used for transmitting user gene sequence real-time data and establishing data communication between the gene acquisition terminal and the cloud server terminal; and the cloud server terminal is used for processing the user gene sequence real-time data, performing gene sequence comparison and variation detection, and determining a gene sequence comparison result and a gene sequence comparison and variation detection result. The invention solves the problem of poor gene sequence comparison and variation detection effect caused by incapability of effectively comparing the gene sequences and effectively detecting and positioning the variation condition of the gene sequences in the prior art. According to the invention, the gene sequences can be effectively compared, the variation condition of the gene sequences can be effectively detected and positioned, and the gene sequence comparison and variation detection effects can be improved.

The invention discloses a floating roof tank guide column sealing device which comprises a sealing plate and a guide column. One end of the sealing plate is a floating disc, and the other end is an elastic plate; the elastic plate is annularly clung to the guide post, and the height of the elastic plate is determined by the saturated vapor pressure of the oil product; the oil product is stored below the floating disc, and oil gas generated by the oil product is located between the floating disc and the oil product. According to the device, by means of the pressure effect of crude oil, gas existing above the oil product is sealed and does not leak outwards; the corresponding oil pressure and the height of the elastic plate are selected, so that the effects of saving the cost, reducing the oil gas loss and protecting the atmosphere are achieved.

Treatment of hyperinsulinemic hypoglycemia comprises administration of an effective amount of a glucagon-like peptide-1 receptor antagonist (GLP1RA) alone or in combination with an amylinomimetic agent or any anti-gastric emptying agent. Patients suffering from hyperinsulinemic hypoglycemia after bariatric surgery experience particular benefit, as there is no current method effective for their treatment. Prevention or reduction of acute adverse effects of postprandial hypoglycemia, such as palpitations, tremor, weakness, sweating, confusion, fatigue, blurred vision, seizures, or loss of consciousness, and prevention of chronic adverse effects of hyperinsulinemic hypoglycemia, such as cognitive impairment, can be achieved by treatment with GLP1RA.

The invention provides a method, a system and equipment for quickly calculating whole genome off-target site editing efficiency. By optimizing the off-target site interval file, introducing strict quality control, avoiding unnecessary re-comparison steps and utilizing the multi-thread and random access characteristics, the calculation efficiency of the whole genome off-target site editing efficiency is improved, the resource consumption is reduced, and the accuracy of the editing efficiency calculation result is improved.

Treatment of hyperinsulinemic hypoglycemia comprises administration of an effective amount of a glucagon-like peptide-1 receptor antagonist (GLP1RA) alone or in combination with an amylinomimetic agent or any anti-gastric emptying agent. Patients suffering from hyperinsulinemic hypoglycemia after bariatric surgery experience particular benefit, as there is no current method effective for their treatment. Prevention or reduction of acute adverse effects of postprandial hypoglycemia, such as palpitations, tremor, weakness, sweating, confusion, fatigue, blurred vision, seizures, or loss of consciousness, and prevention of chronic adverse effects of hyperinsulinemic hypoglycemia, such as cognitive impairment, can be achieved by treatment with GLP1RA.

The present invention relates to the field of information processing technology, and in particular to a method for intelligently pushing information data based on a customized window. The method comprises the following steps: obtaining information platform behavior log record data and performing behavior mining analysis to obtain information platform user browsing behavior data and information platform user search behavior data; constructing a user behavior preference matrix for the information platform user browsing behavior data and the information platform user search behavior data to obtain an information platform user behavior preference feature matrix; performing browsing information screening processing and context association perception analysis on the information platform behavior log record data to obtain an information context association perception sequence data set; performing information push rule mining analysis and intelligent matching push processing based on the information platform user behavior preference feature matrix and the information context association perception sequence data set to obtain an information intelligent matching push sequence set. The present invention can realize the intelligent push of information content that meets user preference requirements.

Treatment of hyperinsulinemic hypoglycemia comprises administration of an effective amount of a glucagon-like peptide-1 receptor antagonist (GLP1RA) alone or in combination with an amylinomimetic agent or any anti-gastric emptying agent. Patients suffering from hyperinsulinemic hypoglycemia after bariatric surgery experience particular benefit, as there is no current method effective for their treatment. Prevention or reduction of acute adverse effects of postprandial hypoglycemia, such as palpitations, tremor, weakness, sweating, confusion, fatigue, blurred vision, seizures, or loss of consciousness, and prevention of chronic adverse effects of hyperinsulinemic hypoglycemia, such as cognitive impairment, can be achieved by treatment with GLP1RA.